טוען...
Treatment Stratification of Patients with Metastatic Castration-Resistant Prostate Cancer by Machine Learning
Prostate cancer is the most common cancer in men in the Western world. One-third of the patients with prostate cancer will develop resistance to hormonal therapy and progress into metastatic castration-resistant prostate cancer (mCRPC). Currently, docetaxel is a preferred treatment for mCRPC. Howeve...
שמור ב:
| הוצא לאור ב: | iScience |
|---|---|
| Main Authors: | , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Elsevier
2019
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6976944/ https://ncbi.nlm.nih.gov/pubmed/31978751 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.isci.2019.100804 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|